Prosthetic Heart Valves: A Global Strategic Business Report
San Jose, CA (PRWEB) April 04, 2012
Follow us on LinkedIn – Prosthetic heart valves are used to replace malfunctioning, diseased or deformed native valve in order to maintain the normal functioning of the heart. Ageing demographics represent a major driving force behind the market’s steady growth as chances of heart valve failure generally increases with age. In addition, rising incidence of obesity and diabetes, which lead to various heart diseases and subsequently to valve malfunction, are expected to drive procedure volumes.
A large portion of the market growth continues to emanate from tissue heart valves segment that accounts for significant share of the total market. Led by the bioprosthetic transcatheter valves, tissue valves are expected to further wean market share from the mechanical valve segment. Technological advancements facilitating better hemodynamics and improved durability of the new generation tissue valves are expected to encourage market prospects. Further the recent FDA approval of Edwards Lifesciences’ TAVI device, Sapiens in late 2011 marks an important event in the prosthetic heart valves market, unfolding new avenues for growth for similar devices awaiting approval. The device which is the first bioprosthetic valve to gain FDA approval is currently approved for use in patients with severe symptomatic aortic stenosis. Another landmark achievement during the year end was the completion of randomized clinical trial for Abbott Laboratories’ MitraClip, a percutaneous device for mitral valve disease.
As stated by the new market research report on Prosthetic Heart Valves, the US represents the largest regional market. Europe represents the other significant market for prosthetic heart valves. European prosthetic heart valve market is primarily driven by the TAVI procedure which is gaining increased penetration, since its introduction in 2007. Asia represents the fastest growing market for prosthetic valves. Economic development in the region and the resultant rise in per capita income, signify that an increasing number of people can now afford the highly expensive valve replacement surgery. Further countries such as India are emerging as a hotspot for medical tourism, attracting hordes of patients from the developed world for heart valve replacement surgery.
Prosthetic heart valves market is highly competitive and intense. Major players profiled in the report include Edwards Lifesciences, St. Jude Medical, Medtronic Abbott Vascular, CryoLife, Inc., On-X Life Technologies, Inc., and the SORIN GROUP, among others.
The research report titled "Prosthetic Heart Valves: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, competition and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) for global and regional markets including the US, Europe, Asia-Pacific, and the Rest of World. Product segments analyzed include tissue heart valves and mechanical heart valves.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/